Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:09 AM
Ignite Modification Date:
2025-12-25 @ 2:09 AM
NCT ID:
NCT00002060
Eligibility Criteria:
Exclusion Criteria
Concurrent Medication:
Excluded:
* Cardiac glycosides.
Patients with the following are excluded:
* AIDS.
* Presenting with chronic candida infection-colo/rectal, oral/pharyngeal, cutaneous (finger/toenails) - for = or \> 3 months who have not responded to therapy.
* Critical illness.
* Hemophilia.
Prior Medication:
Excluded within 1 month of study entry:
* Steroids.
* Cytotoxic immunosuppressive agents.
* Radiotherapy and/or systemic antiviral medication.
* Immunomodulators (including Isoprinosine).
Prior Treatment:
Excluded within 1 month of study entry:
* Radiotherapy.
History of gout, uric acid urolithiasis, uric acid nephrolithiasis, or renal dysfunction.
* Lymphoid malignancy.
Homosexual male patients with AIDS related complex (ARC).
Current IV drug abuse.
Healthy Volunteers:
False
Sex:
MALE
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT00002060
Study Brief:
Protocol Section:
NCT00002060